Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/24/2005 | EP1566387A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
08/24/2005 | EP1565737A2 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof |
08/24/2005 | EP1565551A2 Programmable scaffold and methods for making and using the same |
08/24/2005 | EP1565550A1 Method for isolation of pluripotent stem cells |
08/24/2005 | EP1565549A1 Method for the preparation, purification and differentiation of neurospheres from mammalian stem cells |
08/24/2005 | EP1565548A2 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells |
08/24/2005 | EP1565489A2 Novel raag10 cell surface target and a family of antibodies recognizing that target |
08/24/2005 | EP1565230A2 Material compositions and related systems and methods for treating cardiac conditions |
08/24/2005 | EP1565218A2 Molecules preferentially associated with effector t cells and methods of their use |
08/24/2005 | EP1565199A2 Therapeutic polypeptides,nucleic acids encoding same, and methods of use |
08/24/2005 | EP1478737B1 Cmos process-compatible high dielectric constant surface coating for the detection and stimulation of biological tissue |
08/24/2005 | EP1290150B1 Cutinase variants |
08/24/2005 | EP1246919B1 Progenitor cell preservation factors and related methods and products |
08/24/2005 | EP1038014B1 VEGETABLE (GntI) SEQUENCES AND THE USE THEREOF TO OBTAIN PLANTS WITH A REDUCED OR LACK OF N-ACETYLGLUCOSAMINYLTRANSFERASE I (GnTI) ACTIVITY |
08/24/2005 | EP0906429B1 Cysteine protease promoter from oil seed rape and a method for the containment of plant germplasm |
08/24/2005 | EP0792370B1 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
08/24/2005 | EP0684955B1 Nuclear matrix proteins |
08/24/2005 | EP0662132B1 Self-assembling recombinant hpv16 papillomavirus capsid proteins |
08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
08/24/2005 | CN1659284A Improved chimeric glycoproteins and pseudotyped lentiviral vectors |
08/24/2005 | CN1659281A Antiviral therapy on the basis of RNA interference |
08/24/2005 | CN1659277A Novel phospholipases and uses thereof |
08/24/2005 | CN1659276A Phospholipases, nucleic acids encoding them and methods for making and using them |
08/24/2005 | CN1659274A Cytokine receptor |
08/24/2005 | CN1659273A Control of ES cell self renewal and lineage specification, and medium therefor |
08/24/2005 | CN1659185A Method for producing monoclonal antibodies |
08/24/2005 | CN1659180A Novel recombinant anticoagulant proteins |
08/24/2005 | CN1658940A Cell separation compositions and methods |
08/24/2005 | CN1657630A Process for constructing transgenosis cucumber using mannoheptose as screening marker |
08/24/2005 | CN1657620A Characterisation of gene function using double stranded (ds) RNA inhibition |
08/24/2005 | CN1657610A Human embryonic stem cells culture medium without dependent feeding cell |
08/24/2005 | CN1657609A Method for preserving external hepatic cell system |
08/24/2005 | CN1657604A Preparation and using method of culture medium |
08/24/2005 | CN1216149C Cell strain of expression mutation type human tissue plasminogen activator imethod for construction and preparation method of expressing protein |
08/24/2005 | CN1216148C Culturing method for Dendrobium offieinale |
08/24/2005 | CN1216076C Monoclonal antibody resisting human small cell lung carcinoma and its application |
08/23/2005 | US6933425 Inbred maize line PH91C |
08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
08/23/2005 | US6933375 mcFP encoding nucleic acids, polypepetides, antibodies and methods of use thereof |
08/23/2005 | US6933285 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents |
08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
08/23/2005 | US6933149 Propagation of mouse throat tissue; obtain throat tissue, insert cell into air/liquid nutrient broth, propagate cells |
08/23/2005 | US6933148 Cell separation compositions and methods |
08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
08/23/2005 | US6933145 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
08/23/2005 | US6933144 Apparatus for growing cells |
08/23/2005 | US6933142 Mammalian glycosylsulfotransferases expressed in high endothelial cells (HEC-GLCNAC6ST) and polypeptides coded by nucleic acids, used for medical diagnosis, drug screening and therapy |
08/23/2005 | US6933135 monoclonal antibody having intracellular domain of leukocyte antigen related molecule and domain of CD45; for prophylaxis and diagnosis of syndrome X, arteriosclerosis, and cardiovascular disorders based on insulin resistance |
08/23/2005 | US6933131 Nucleotide sequences for use in biological pest control; insecticides |
08/23/2005 | US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1 |
08/23/2005 | US6933129 Method for culturing and assaying cells |
08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
08/23/2005 | US6933124 Human GABAB receptor 1 promoters |
08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
08/23/2005 | US6932977 Method of inducing or enhancing chondrogenesis with extracellular matrix containing BMP-4 |
08/23/2005 | US6932804 System and method for forming a non-ablative cardiac conduction block |
08/23/2005 | CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties |
08/23/2005 | CA2193122C Tetracycline-regulated transcriptional modulators |
08/23/2005 | CA2190261C Method of immunomodulation by means of adoptive transfer of antigen-specific cytotoxic t-cells |
08/23/2005 | CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
08/23/2005 | CA2108000C Enhanced gene expression in plants using an hsp70 intron sequence |
08/18/2005 | WO2005075652A1 Process for producing modified ϝ-glutamyltranspeptidase (modified ggt) having enhanced glutaryl-7-aminosephalosporanic acid (gl-7-aca) acylase activity |
08/18/2005 | WO2005075629A1 A method and apparatus for orienting spherical cells |
08/18/2005 | WO2005075628A1 Deactivated b1b cell |
08/18/2005 | WO2005074676A1 Genetic modification of c57 mice |
08/18/2005 | WO2005074357A2 Regulation of gene expression in plant cells |
08/18/2005 | WO2005061545A3 Nogoa antibodies for the treatment of alzheimer disease |
08/18/2005 | WO2005061544A3 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
08/18/2005 | WO2005060740A3 An improved method for embryo and animal production |
08/18/2005 | WO2005054424A3 Bioactive boxes for cellular cultures |
08/18/2005 | WO2005051436A3 Method for tooth organ reconstruction |
08/18/2005 | WO2005047487A8 Motoneuronotrophic factor gene sequences |
08/18/2005 | WO2005047464A3 Cell culture tool and method |
08/18/2005 | WO2005042723A9 Novel multipotent stem cells and use thereof |
08/18/2005 | WO2005028626A3 Cell culture media |
08/18/2005 | WO2005027841A3 Cells, compositions and methods for repressing b cell autoantibody secretion and for treating autoimmune disease |
08/18/2005 | WO2005026318A3 Methods and compositions for producing antigenic responses |
08/18/2005 | WO2005025493A3 Biological engineering of articular structures containing both cartilage and bone |
08/18/2005 | WO2005023980A3 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
08/18/2005 | WO2005023865A3 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
08/18/2005 | WO2005020924A3 A rapid way to obtain high expression clones of mammalian cells using a methylcellulose and immunoprecipitation screening method |
08/18/2005 | WO2005018549A3 Methods and compositions for tissue repair |
08/18/2005 | WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus |
08/18/2005 | WO2005013899A3 Compositions and methods for the therapy and diagnosis of lung cancer |
08/18/2005 | WO2005006944A3 Devices and methods for assessing spinal and implant motion and for optimizing alignment and movement |
08/18/2005 | WO2004094597A3 Anthozoan fluorescent protein genes |
08/18/2005 | WO2004062366A3 Stem-regulated, plant defense promoter and uses thereof in tissue-specific expression in monocots |
08/18/2005 | WO2004039578A8 Biodegradable substrate, prosthetic material for tissue regeneration and cultured tissue |
08/18/2005 | WO2002099049A3 Tbc1d1s as modifiers of the p53 pathway and methods of use |
08/18/2005 | WO2001058923A9 Improved systems for sensitive detection of g-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
08/18/2005 | US20050183168 Plants having decreased dormancy period and methods producing the plants |
08/18/2005 | US20050183155 herbicide resistance, insect resistance, resistance for bacterial, fungal, or viral disease, male fertility, male sterility, enhanced nutritional quality, and industrial usage |
08/18/2005 | US20050183154 the plant has such traits as herbicide resistance, insect resistance, resistance for bacterial, fungal, or viral disease, male fertility, male sterility, enhanced nutritional quality, and industrial usage |
08/18/2005 | US20050183153 Soybean cultivar 0509251 |
08/18/2005 | US20050183152 Soybean cultivar 2386009 |
08/18/2005 | US20050183148 Lymphocyte surface receptor that binds caml and methods of use thereof |
08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
08/18/2005 | US20050182016 promoter, the basal transcription regulatory region, and the transcription factor binding sites which are located upstream of, and are operatively linked to, the CRMP-1 gene; transfected cells |
08/18/2005 | US20050182010 Use of a nucleotide construct stably integrated in the genome of the target cells of the virus, which is able to produce a single transcript or multiple transcripts capable of forming a double-stranded RNA which inhibits replication of the virus |
08/18/2005 | US20050181997 For preservation of hematopoietic progenitor cells; useful for isolating rare, primitive progenitor cells; nontoxic |